Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritis

Usefulness of monitoring of B cell depletion in rituximab-treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational study

(2015) A.-P. Trouvin et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients

(2014) J. Westra et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Arthritis susceptibility and the gut microbiome

(2014) Veena Taneja   FEBS LETTERS

Predictive Factors of Response to Biological Disease Modifying Antirheumatic Drugs: Towards Personalized Medicine

(2014) Claire I. Daïen et al.   MEDIATORS OF INFLAMMATION

The Link Between Periodontal Disease and Rheumatoid Arthritis: An Updated Review

(2014) Joanna Koziel et al.   Current Rheumatology Reports

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

(2013) Josef S Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

Longterm Effects of Rituximab on B Cell Counts and Autoantibody Production in Rheumatoid Arthritis: Use of High-sensitivity Flow Cytometry for More Sensitive Assessment of B Cell Depletion

(2013) A. Vancsa et al.   JOURNAL OF RHEUMATOLOGY

B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies

(2013) Maria J Leandro   ARTHRITIS RESEARCH & THERAPY

Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis

(2012) Gianfranco Ferraccioli et al.   PLoS One

Total serum immunoglobulin levels in patients with RA after multiple B-cell depletion cycles based on rituximab: relationship with B-cell kinetics

(2012) Inmaculada De La Torre et al.   RHEUMATOLOGY

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis

(2011) M. H. Buch et al.   ANNALS OF THE RHEUMATIC DISEASES

The ACPA recognition profile and subgrouping of ACPA-positive RA patients

(2011) Annemiek Willemze et al.   ANNALS OF THE RHEUMATIC DISEASES

Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis

(2011) Jérémie Sellam et al.   ARTHRITIS AND RHEUMATISM

A Comparison Between IgG- and IgA-class Antibodies to Cyclic Citrullinated Peptides and to Modified Citrullinated Vimentin in Early Rheumatoid Arthritis and Very Early Arthritis

(2011) A. SVARD et al.   JOURNAL OF RHEUMATOLOGY

Effectiveness of Rituximab in Patients with Rheumatoid Arthritis: Observational Study from the British Society for Rheumatology Biologics Register

(2011) M. M. SOLIMAN et al.   JOURNAL OF RHEUMATOLOGY

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

(2010) Daniel Aletaha et al.   ARTHRITIS AND RHEUMATISM

Predictive factors of response to rituximab therapy in rheumatoid arthritis: What do we know today?

(2010) Maurizio Benucci et al.   AUTOIMMUNITY REVIEWS

Steady-state generation of mucosal IgA+ plasmablasts is not abrogated by B-cell depletion therapy with rituximab

(2010) H. E. Mei et al.   BLOOD

Memory B and memory plasma cells

(2010) Taketoshi Yoshida et al.   IMMUNOLOGICAL REVIEWS

Meta-analysis: diagnostic value of serum anti-mutated citrullinated vimentin antibodies in patients with rheumatoid arthritis

(2010) Xue Qin et al.   RHEUMATOLOGY INTERNATIONAL

Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins

(2010) Katleen Van Steendam et al.   ARTHRITIS RESEARCH & THERAPY

The Disease Activity Score and the EULAR Response Criteria

(2009) Jaap Fransen et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis

(2009) L. Quartuccio et al.   RHEUMATOLOGY

Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response

(2009) Magda Nakou et al.   ARTHRITIS RESEARCH & THERAPY

Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease

(2008) Andreea Ioan-Facsinay et al.   ARTHRITIS AND RHEUMATISM

Blood-borne human plasma cells in steady state are derived from mucosal immune responses

(2008) H. E. Mei et al.   BLOOD